Stock KRMD KORU MEDICAL SYSTEMS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings KORU Medical Systems, Inc.

Equities

KRMD

US7599101026

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for KORU Medical Systems, Inc. +6.31% -10.79%
Mar. 13 Transcript : KORU Medical Systems, Inc., Q4 2023 Earnings Call, Mar 13, 2024
Mar. 13 KORU Medical Systems, Inc. Enters into Loan and Security Agreement with HSBC Ventures USA Inc CI

Strengths

  • Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 64% by 2026.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
  • Low profitability weakens the company.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
  • The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
KORU MEDICAL SYSTEMS, INC. Stock KORU Medical Systems, Inc.
-10.79% 102M
C
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.92% 185B
C+
MEDTRONIC PLC Stock Medtronic plc
-3.80% 107B
C
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.48% 67.55B
A
DEXCOM, INC. Stock DexCom, Inc.
+11.22% 54.6B
B-
CENCORA, INC. Stock Cencora, Inc.
+16.74% 47.42B
B-
HOYA CORPORATION Stock Hoya Corporation
+3.86% 42.24B
B+
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+4.56% 28.24B
A-
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+1.64% 26.42B
B
TERUMO CORPORATION Stock Terumo Corporation
+12.40% 25.66B
A-
Investor Rating
Trading Rating
ESG Refinitiv

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
-
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Environment

Emissions
Innovation
Use of resources

Social

Social commitment
Human Rights
Product liability
Human Resources

Governance

CSR Strategy
Management
Shareholders

Controversy

Controversy

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. KRMD Stock
  4. Ratings KORU Medical Systems, Inc.